Search Results - PROGRAMMED cell death 1 receptors

Authors: Chang, Xu¹ (AUTHOR), Li, Xinge² (AUTHOR), Sun, Peng¹ (AUTHOR), Li, Zhenfeng¹ (AUTHOR), Sun, Pengfei³ (AUTHOR) drsunpengfei@sina.com, Ning, Shangkun⁴ (AUTHOR) ningskun@163.com

Superior Title: BMC Cancer. 4/16/2024, Vol. 24 Issue 1, p1-11. 11p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *ADVERSE health care events, *BILE ducts, *OVERALL survival, *PROGRESSION-free survival

HTML Full Text PDF Full Text

5

Academic Journal

PD-1/PD-L1 axis induced host immunosuppression via PI3K/Akt/mTOR signalling pathway in piglets infected by Glaesserella Parasuis.

Authors: Li, Jingyang^1,2 (AUTHOR), Liu, Siyu^1,2 (AUTHOR), Dong, Qiaoli^1,2 (AUTHOR), Fu, Yunjian^1,2 (AUTHOR), Sun, Yamin^1,2 (AUTHOR), Luo, Ronghui^1,2 (AUTHOR), Tian, Xinyue^1,2 (AUTHOR), Guo, Ling^1,2 (AUTHOR), Liu, Wei^1,2 (AUTHOR), Qiu, Yinsheng^1,2 (AUTHOR), Lu, Qirong^1,2 (AUTHOR), Ye, Chun^1,2 (AUTHOR), Zong, Bingbing^1,2 (AUTHOR), Fu, Shulin^1,2 (AUTHOR) shulinfu@whpu.edu.cn

Superior Title: BMC Veterinary Research. 4/6/2024, Vol. 20 Issue 1, p1-14. 14p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *CELLULAR signal transduction, *T cell differentiation, *IMMUNOSUPPRESSION, *PROTEOMICS

HTML Full Text PDF Full Text

6

Academic Journal

Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.

Authors: Yang, Xu^1,2 (AUTHOR), Lian, Baofeng³ (AUTHOR), Zhang, Nan¹ (AUTHOR), Long, Junyu¹ (AUTHOR), Li, Yiran¹ (AUTHOR), Xue, Jingnan¹ (AUTHOR), Chen, Xiangqi¹ (AUTHOR), Wang, Yunchao¹ (AUTHOR), Wang, Yanyu¹ (AUTHOR), Xun, Ziyu¹ (AUTHOR), Piao, Mingjian¹ (AUTHOR), Zhu, Chenpei¹ (AUTHOR), Wang, Shanshan¹ (AUTHOR), Sun, Huishan¹ (AUTHOR), Song, Zhijian³ (AUTHOR), Lu, Leilei³ (AUTHOR), Dong, Xiaowei³ (AUTHOR), Wang, Aodi³ (AUTHOR), Liu, Wenjin³ (AUTHOR), Pan, Jie⁴ (AUTHOR)

Superior Title: BMC Medicine. 1/29/2024, Vol. 22 Issue 1, p1-14. 14p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *MICROSATELLITE repeats, *CHOLANGIOCARCINOMA, *IMMUNOTHERAPY, *NUCLEOTIDE sequencing, *PROGRAMMED death-ligand 1

HTML Full Text PDF Full Text

7

Academic Journal

ncRNAs-mediated TIMELESS overexpression in lung adenocarcinoma correlates with reduced tumor immune cell infiltration and poor prognosis.

Authors: Gao, Xinliang¹ (AUTHOR), Tang, Mingbo¹ (AUTHOR), Tian, Suyan² (AUTHOR), Li, Jialin¹ (AUTHOR), Wei, Shixiong¹ (AUTHOR), Hua, Shucheng³ (AUTHOR), Liu, Wei¹ (AUTHOR) l_w01@jlu.edu.cn

Superior Title: PLoS ONE. 1/23/2024, Vol. 19 Issue 1, p1-12. 12p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *COMPETITIVE endogenous RNA, *TH2 cells, *GENETIC overexpression, *IMMUNE checkpoint inhibitors, *NON-coding RNA

HTML Full Text PDF Full Text

8

Academic Journal

Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations.

Authors: Ding, Wuwu¹ (AUTHOR), Yang, Pengmin^2,3 (AUTHOR), Zhao, Xiaokai^2,3 (AUTHOR), Wang, Xiaozhi² (AUTHOR), Liu, Huaqing² (AUTHOR), Su, Qing² (AUTHOR), Wang, Xintao³ (AUTHOR), Li, Jieyi^2,3 (AUTHOR), Gong, Ziying^2,3 (AUTHOR), Zhang, Daoyun^2,3 (AUTHOR) zdy@yunyingmedicine.com, Wang, Xinwei⁴ (AUTHOR) xinweiwang926@gmail.com

Superior Title: Respiratory Research. 1/18/2024, Vol. 25 Issue 1, p1-11. 11p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *LUNG cancer, *NON-small-cell lung carcinoma, *IMMUNOSTAINING, *KINASE inhibitors

HTML Full Text PDF Full Text

9

Academic Journal

Genome-wide analyses reveal the contribution of somatic variants to the immune landscape of multiple cancer types.

Authors: Bi, Wenjian^1,2,3 (AUTHOR), Xu, Zhiyu⁴ (AUTHOR), Liu, Feng⁴ (AUTHOR), Xie, Zhi⁴ (AUTHOR), Liu, Hao⁴ (AUTHOR), Zhu, Xiaotian⁴ (AUTHOR), Zhong, Wenge⁴ (AUTHOR), Zhang, Peipei^5,6 (AUTHOR) peipei.zhang@pku.edu.cn, Tang, Xing⁴ (AUTHOR) peipei.zhang@pku.edu.cn

Superior Title: PLoS Genetics. 1/19/2024, Vol. 20 Issue 1, p1-21. 21p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *T cells, *T-cell exhaustion, *NON-small-cell lung carcinoma, *IMMUNE checkpoint proteins, *CANCER cells, *GENOME-wide association studies

HTML Full Text PDF Full Text

10

Academic Journal

Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non–small-cell lung cancer.

Authors: Liu, Li^1,2 (AUTHOR), Zhang, Shuo³ (AUTHOR), Yang, Hai-Yan² (AUTHOR), Zhou, Chun-Hua² (AUTHOR), Xiong, Yi² (AUTHOR), Yang, Nong² (AUTHOR) yangnong0217@163.com, Tian, Ye¹ (AUTHOR) dryetian@126.com

Superior Title: Lipids in Health & Disease. 1/13/2024, Vol. 23 Issue 1, p1-14. 14p.

Subject Terms: *NON-small-cell lung carcinoma, *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *LIPIDS, *LIPID metabolism, *THERAPEUTICS

HTML Full Text PDF Full Text

11

Academic Journal

Prognostic value and immunological role of PD-L1 gene in pan-cancer.

Authors: Wang, Yongfeng^1,2,3,4 (AUTHOR), Jiang, Hong⁵ (AUTHOR), Fu, Liangyin² (AUTHOR), Guan, Ling⁵ (AUTHOR), Yang, Jiaxin⁵ (AUTHOR), Ren, Jingyao² (AUTHOR), Liu, Fangyu¹ (AUTHOR), Li, Xiangyang¹ (AUTHOR), Ma, Xuhui² (AUTHOR), Li, Yonghong⁴ (AUTHOR) haifenglyh@126.com, Cai, Hui^1,2,3,4 (AUTHOR) caialonteam@163.com

Superior Title: BMC Cancer. 1/2/2024, Vol. 24 Issue 1, p1-19. 19p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *PROGNOSIS, *IMMUNE checkpoint proteins, *IMMUNOHISTOCHEMISTRY, *RECEIVER operating characteristic curves

HTML Full Text PDF Full Text

12

Academic Journal

The expression and significance of PD‐L1 in condyloma acuminatum.

Authors: Liu, Yamei¹ (AUTHOR), Huang, Weiqi² (AUTHOR), Yang, Kun¹ (AUTHOR), Du, Xiangxi¹ (AUTHOR), Guo, Xueyun¹ (AUTHOR), Cao, Yuchun¹ (AUTHOR) 963808187@qq.com

Superior Title: Skin Research & Technology. Jan2024, Vol. 30 Issue 1, p1-9. 9p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *GENE expression, *PROGRAMMED death-ligand 1, *HUMAN papillomavirus, *GENITAL warts, *INHIBITION of cellular proliferation

HTML Full Text PDF Full Text

13

Academic Journal

Programmed Cell Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Equine Melanocytic Tumors.

Authors: Pimenta, José^1,2,3 (AUTHOR) josepimenta@utad.pt, Prada, Justina^1,2,4 (AUTHOR) ipires@utad.pt, Pires, Isabel^1,2,4 (AUTHOR) mcotovio@utad.pt, Cotovio, Mário^1,2,5 (AUTHOR)

Superior Title: Animals (2076-2615). Jan2024, Vol. 14 Issue 1, p48. 14p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *MELANOMA, *BENIGN tumors, *CLINICAL trials

HTML Full Text PDF Full Text

14

Academic Journal

Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis.

Authors: Wang, Yanrong^1,2 (AUTHOR), Li, Lingling³ (AUTHOR), Hu, Jia^4,5 (AUTHOR), Zhao, Yan⁴ (AUTHOR), Yan, Huan⁴ (AUTHOR), Gao, Ming⁴ (AUTHOR), Yang, Xuejiao⁴ (AUTHOR), Zhang, Xia⁴ (AUTHOR) zx6055215@163.com, Ma, Junxun⁴ (AUTHOR) majunxun74@126.com, Dai, Guanghai⁴ (AUTHOR) dgh19661007@126.com

Superior Title: BMC Cancer. 12/6/2023, Vol. 23 Issue 1, p1-12. 12p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *SMALL cell lung cancer, *LUNG cancer, *IMMUNE checkpoint inhibitors

HTML Full Text PDF Full Text

15

Academic Journal

Identification of a Novel CD8⁺ T cell exhaustion-related gene signature for predicting survival in hepatocellular carcinoma.

Authors: Liu, Kejun^1,2 (AUTHOR), Liu, Junhao^2,3 (AUTHOR), Zhang, Xusheng^1,2 (AUTHOR), Liu, Di^1,2 (AUTHOR), Yao, Weijie^1,2 (AUTHOR), Bu, Yang^2,3 (AUTHOR) buyang1976@163.com, Chen, Bendong^1,2 (AUTHOR) bendong8511@hotmail.com

Superior Title: BMC Cancer. 12/4/2023, Vol. 23 Issue 1, p1-15. 15p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *HEPATOCELLULAR carcinoma, *T-cell exhaustion, *T cells, *PROGNOSTIC models, *DISEASE risk factors, *SMALL interfering RNA

HTML Full Text PDF Full Text

16

Academic Journal

Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin's lymphoma: a systematic review and meta-analysis of 20 prospective studies.

Authors: Sun, Chenxi¹ (AUTHOR), Chen, Huixian² (AUTHOR), Wang, Yongjing^3,4,5 (AUTHOR) wangyongjing2015@163.com, Zheng, Chengyun^3,4,5 (AUTHOR) zhengzhengwei@hotmail.com

Superior Title: Hematology. Dec2023, Vol. 28 Issue 1, p1-12. 12p.

Subject Terms: *HODGKIN'S disease, *PROGRAMMED cell death 1 receptors, *PROGRAMMED death-ligand 1, *TERMINATION of treatment, *WEIGHT gain

HTML Full Text PDF Full Text

17

Academic Journal

Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma.

Authors: Peng, Xiaopeng^1,2 (AUTHOR), Yu, Ziwen^1,2 (AUTHOR), Surineni, Goverdhan^1,2 (AUTHOR), Deng, Bulian^1,2 (AUTHOR), Zhang, Meizhu^1,2 (AUTHOR), Li, Chuan^1,2 (AUTHOR), Sun, Zhiqiang^1,2 (AUTHOR), Pan, Wanyi^1,2 (AUTHOR), Liu, Yao³ (AUTHOR), Liu, Shenglan^1,2 (AUTHOR) liushl5@gmu.edu.cn, Yu, Bin⁴ (AUTHOR) zzuyubin@hotmail.com, Chen, Jianjun^1,2 (AUTHOR) jchen21@smu.edu.cn

Superior Title: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2023, Vol. 38 Issue 1, p1-16. 16p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *SMALL molecules, *MELANOMA, *T cells, *BRAF genes, *IMMUNOTHERAPY, *ANTINEOPLASTIC agents, *HISTONE deacetylase, *TUBULINS

HTML Full Text PDF Full Text

18

Academic Journal

Discovery of the SHP2 allosteric inhibitor 2-((3R,4R)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-(2,3-dichlorophenyl)-3-methylpyrrolo[2,1-f][1,2,4] triazin-4(3H)-one.

Authors: Luo, Yanmei¹ (AUTHOR), Li, Jin² (AUTHOR), Zong, Yuliang¹ (AUTHOR), Sun, Mengxin¹ (AUTHOR), Zheng, Wan¹ (AUTHOR), Zhu, Jiapeng^1,3 (AUTHOR), Liu, Liu² (AUTHOR) liu_liu@PharmaBlock.com, Liu, Bing^1,3 (AUTHOR) bingliu@njucm.edu.cn

Superior Title: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2023, Vol. 38 Issue 1, p398-404. 7p.

Subject Terms: *PROGRAMMED cell death 1 receptors, *PROTEIN-tyrosine phosphatase, *APOPTOSIS, *PHOSPHOPROTEIN phosphatases, *CELL communication, *STRUCTURE-activity relationships

HTML Full Text PDF Full Text

19

Academic Journal

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.

Authors: Luo, Jian¹ (AUTHOR), Xiao, Wanying¹ (AUTHOR), Hua, Fengyang¹ (AUTHOR), Cao, Yanqing¹ (AUTHOR), Wang, Dongxia² (AUTHOR) dongxiadg@163.com, Wang, Xicheng¹ (AUTHOR) 13902400598@126.com

Superior Title: BMC Cancer. 11/30/2023, Vol. 23 Issue 1, p1-12. 12p.

Subject Terms: *NASOPHARYNX cancer, *PROGRAMMED cell death 1 receptors, *PEMETREXED, *ADVERSE health care events, *NASOPHARYNX diseases, *SCIENCE databases, *WEB databases, NASOPHARYNX tumors

HTML Full Text PDF Full Text

20

Academic Journal

Immunosignatures associated with TP53 status and co-mutations classify prognostically head and neck cancer patients.

Authors: Sacconi, Andrea¹ (AUTHOR), Muti, Paola^2,3 (AUTHOR), Pulito, Claudio⁴ (AUTHOR), Urbani, Giulia⁴ (AUTHOR), Allegretti, Matteo⁴ (AUTHOR), Pellini, Raul⁵ (AUTHOR), Mehterov, Nikolay^6,7 (AUTHOR), Ben-David, Uri⁸ (AUTHOR), Strano, Sabrina⁹ (AUTHOR), Bossi, Paolo^10,11 (AUTHOR) paolo.bossi@hunimed.eu, Blandino, Giovanni⁴ (AUTHOR) giovanni.blandino@ifo.it

Superior Title: Molecular Cancer. 11/30/2023, p1-11. 11p.

Subject Terms: *HEAD & neck cancer, *PROGRAMMED cell death 1 receptors, *CANCER patients, *IMMUNE checkpoint inhibitors, *GENE expression

HTML Full Text PDF Full Text

Narrow Search